NP34925g Anti-human T lymphocyte immunoglobulin (equine)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1M
- Sector
- HEALTH
- Published
- 02 May 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
The Scottish National Blood Transfusion Service, Edinburgh (SNBTS). OR Upon request: designated delivery points throughout Scotland for use by Participating Authorities.
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Pfizer Tadworth
Description
Supply of Anti-human T lymphocyte immunoglobulin (equine) to NHS Scotland.
Total Quantity or Scope
The Framework Agreement is for the supply of Anti-human T lymphocyte immunoglobulin (equine) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Award Detail
| 1 | Pfizer (Tadworth)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
Although Anti-human T lymphocyte immunoglobulin (equine) (Atgam) has lost patent protection there is no known generic competition in the UK marketplace due to the difficulties in replicating the manufacturing process, in line with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:797782)
Reference
- ocds-h6vhtk-050298
- FTS 018763-2025